AstraZeneca Pharma received import and market permission from DCGI for Calquence - (India Infoline via NewsPoints Desk)

  • AstraZeneca has received import and market permission in Form CT-20 from the Drugs Controller General of India for Calquence, reported India Infoline.

  • The drug, which is also known as acalabrutinib, is indicated for treatment of patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.

To read more NewsPoints articles, click here.